Drugs
Drugs to be Discontinued
Companies are required under 21 CFR 314.81(b)(3)(iii) to provide FDA with a six month advance notice of the discontinuation of sole source products that are life-supporting, life-sustaining or for use in the prevention of a debilitating disease or condition. From time to time, FDA also receives notification for other products. These discontinuations are provided below for informational purposes only. |
To locate drugs that have already been discontinued, please consult the following:
Drugs@FDA
Orange Book Query
Orange Book Monthly Additions and Deletions
Drug Name | Company Information | Related Information |
---|---|---|
Agenerase (amprenavir) 150mg capsule
| GlaxoSmithKline 888-825-5249
| Letter from GlaxoSmithKline (updated 10/10/2007) |
Alcohol in 5% Dextrose Injection, USP, Glass Container 12/19/2007 | Hospira, Inc. 877-946-7747 | Hospira has made a business decision to discontinue manufacturing of 5% Alcohol in 5% Dextrose Injection drug product (NDC# 0409-1500-05) |
Aminophylline Tablets USP, 100 mg and 200 mg
4/4/2012 | West-Ward Pharmaceutical Corp. 1-800-631-2174 | West-Ward has made a business decision to discontinue Aminophylline Tablets. |
Betamethasone Oral Solution 6/5/2012 | Schering Corporation, a subsidiary of Merck & Co. Inc., 1-800-672-6372 | Schering Corporation has made a decision to discontinue this product. |
Brevibloc Concentrate (esmolol HCl) 250 mg/mL, 10 mL ampul 8/24/2007 | Baxter Healthcare Corporation | Baxter Healthcare Corporation has made a decision to discontinue Brevibloc Concentrate (esmolol HCl) 250 mg/mL, 10 mL ampul (NDC 10019-025-18 for the pack and NDC 10019-025-73 for the ampul). Letter from Baxter |
Calciferol injection in oil (ergocalciferol) 3/19/2004 | Schwarz Pharma 6140 W. Executive Drive Mequon, WI 53092 800-558-5114 | Schwarz has discontinued manufacturing of calciferol |
Calcitriol 1 mcg/mL Injection 5/18/2012 | West-Ward Pharmaceuticals Customer Service: 1-888-229-0001 | West-Ward no longer distributes Calcitriol 1 mcg/mL Injection. |
CEFOTAN (cefotetan injection) 6/9/2006 | AstraZeneca Pharmaceuticals LP (AstraZeneca) - Contact Corporate Information Center at 800-236-9933. | The remaining inventory of CEFOTAN (cefotetan injection) has been depleted. AstraZeneca has no further plans to manufacture or distribute CEFOTAN (cefotetan injection). Other cefotetan injection products continue to be available. |
Chloral Hydrate Oral Solution 5/25/2012 | Pharmaceutical Associates, Inc 1-864-277-7282 | PAI has discontinued manufacturing of Chloral Hydrate Oral Solution 16 fl oz retail package (NDC 00121-0532-16) and 5ml Unit Dose (NDC 00121-0532-05). This is solely a business decision from PAI and is not related to any FDA actions. |
Chromitope Sodium (Sodium Chromate Cr 51 Injection USP) 6/5/2012 | Bracco Diagnostics Inc 1-800-631-5245 | Bracco Diagnostics Inc. has made a decision to discontinue the Chromitope sodium effective July 15th, 2012. |
Cognex (tacrine hydrochloride) Capsules, 10 mg, 20 mg 5/24/2012 | Shionogi, Inc. 800-849-9707 | Shionogi has made a business decision to discontinue Cognex® (tacrine hydrochloride), 10 and 20 mg capsules. There is no remaining inventory within Shionogi, Inc. distribution network. |
Cortisporin Ophthalmic Suspension (neomycin and polymyxin B sulfates and hydrocortisone ophthalmic suspension) 6/5/2008 | King Pharmaceuticals 800-776-3637 | Letter from King Pharmaceuticals |
Cortisporin Otic Suspension (neomycin and polymyxin B sulfates and hydrocortisone otic suspension, USP) 6/5/2008 | King Pharmaceuticals 800-776-3637 | Letter from King Pharmaceuticals |
Covera HS (180 mg or 240 mg extended-release verapamil HCl) tablets 6/15/2012 | Pfizer Customer Service: 1-800-438-1985 | Discontinued due to business reasons. |
Cyanide Antidote Kit 5/22/2012 | Akorn Pharmaceuticals 1-800-932-5676 | Akorn is discontinuing the manufacture of this product and the components for use in this product. |
Cylert (pemoline) tablets and chewable tablets, all strengths 5/25/2005 | Abbott Laboratories | Abbott has made the decision to discontinue Cylert tablets and chewable tablets |
Cytoxan (cyclophosphamide) 25mg and 50mg tablets 9/24/2007 | Bristol-Myers Squibb Company 609-897-2412 | Bristol-Myers Squibb Company has made a decision to discontinue Cytoxan (cyclophosphamide) 25mg and 50mg tablets. Alternate products continue to be available from other companies. |
Desyrel (trazodone) Tablets 50mg, 100mg, 150mg and 300mg tablets 9/21/2006 | Bristol-Myers Squibb Company 609-897-2412 | Alternate products continue to be available from other companies. |
Digoxin Injection
| Sandoz Customer Service: 1-609-627-8500 | Sandoz discontinued manufacturing in March 2011. Sandox is no longer distributing with no plans for re-introduction. |
ELAVIL (amitriptyline hydrochloride) Tablets and Injection.
5/15/2003 | AstraZeneca Pharmaceuticals LP (AstraZeneca) – Contact Corporate Information Center at: 800-236-9933 | ELAVIL Injection is no longer available at AstraZeneca. The remaining inventory of ELAVIL Tablets will be depleted by December 31, 2003. AstraZeneca has no further plans to manufacture ELAVIL (amitriptyline hydrochloride) Tablets or Injection. |
(Asparaginase Injection)
08/03/2012 | Lundbeck LLC Customer Service Number: 1-888-514-5204 | Lundbeck will be discontinuing Elspar in December 2012 See Dear Healthcare Provider Letter (PDF -335KB) from Lundbeck (updated 08/03/2012) |
Ephedrine Sulfate Injection 50mg/ml (NDC 00409-3073-31) 2/8/2011 | Hospira, Inc. 1-877-946-7747 | Hospira has made a business decision to discontinue manufacturing this product. Akorn and Sandoz continue to have product available. Dear Valued Customer Letter (PDF - 70KB) |
Ethmozine (moricizine hydrochloride) 200mg, 250g, and 300mg tablets 9/17/2007 | Shire US Inc. 725 Chesterbrook Blvd. Wayne, Pa 19087 1-800-828-2088 | Dear Healthcare Professional Letter |
Exubera (insulin recombinant human, powder for inhalation) 10/19/2007 | Pfizer 800-398-2372 | Dear Healthcare Provider Letter |
Faslodex* (fulvestrant) Injection, 2.5 ml (2 x 2.5 ml pre-filled syringe), (125 mg /2.5 ml (50 mg/ml) FASLODEX intramuscular injection), NDC 0310-0720-2510. Faslodex (fulvestrant) Injection: one 5.0 ml syringe (250mg/5ml), NDC 0310-0720-50
| AstraZeneca Pharmaceuticals LP (AstraZeneca) Contact the Corporate Communication Center at 1-800-236-9933 | There is no remaining inventory within AstraZeneca's distribution network. The final expiration date of any Faslodex* (fulvestrant) Injection that may still be remaining in the market place is December 31, 2010. |
Florinef (fludrocortisone acetate tablets, USP) 6/8/2007 | King Pharmaceuticals, Inc. 501 Fifth Street Bristol, Tennessee 37620 Professional Information Services Department: 800-776-3637 | Dear Healthcare Provider Letter |
Flovent Rotadisk (fluticasone propionate inhalation powder) 8/31/2004 | GlaxoSmithKline 888-825-5249 | Please see Dear Healthcare Professional letter for additional information. |
Fortovase (saquinavir) capsules 200 mg 6/2/2005 | Roche | Fortovase 200 mg capsules will be discontinued by February 15, 2006. Please see attached DHP letter for additional information. |
Foscavir (foscarnet sodium) injection 10/31/2008 | AstraZeneca Pharmaceuticals LP (AstraZeneca) Contact Corporate Information Center at 1-800-236-9933 | The remaining inventory of Foscavir (foscarnet sodium) injection will be depleted by April 30, 2009. AstraZeneca has no further plans to manufacture or distribute Foscavir (foscarnet sodium) injection after April 30, 2009. |
Geocillin (carbenicillin indanyl sodium) tablets 382 mg 4/8/2008 | Pfizer | Pfizer has discontinued this product. There are no other FDA approved manufacturers currently for carbenicillin tablets. |
Geref Diagnostic (sermorelin acetate for injection) 0.05mg base/amp 8/5/2008 | EMD Serono 1-888-398-4567 | EMD Serono has made a business decision to discontinue this product. |
Heparin Sodium in 5% Dextrose premix product 3/18/2011 | Baxter Customer Service: (1-888-229-0001) | Heparin Sodium and 0.9% Sodium Chloride Injection product remains available. |
Humatin (Paromomycin Sulfate Capsules, USP)
2/7/2008 | King Pharmaceuticals Professional Information Services Department 800-776-3637 | King Pharmaceuticals has made a decision to discontinue Humatin (Paromomycin Sulfate Capsules, USP) Paromomycin continues to be available from another manufacture.
|
updated
| Eli Lilly and Company 1-800-545-5979 | |
Humulin U ULTRALENTE (HUMAN INSULIN [rDNA ORIGIN] EXTENDED ZINC SUSPENSION) 7/6/2005 | Eli Lilly and Company | |
Humulin L LENTE (HUMAN INSULIN [rDNA ORIGIN] ZINC SUSPENSION) 7/6/2005 | Eli Lilly and Company |
|
HIVID (zalcitabine) tablets 7/26/2006 | Roche Pharmaceuticals | The sale and distribution of its anti-HIV |
Intal Inhaler (cromolyn sodium inhalation aerosol) 8/3/2009 | King Pharmaceuticals | Dear Healthcare Professional Letter |
Intal Nebulizer Solution (cromolyn sodium inhalation solution, USP) 6/2/2008 | King Pharmaceuticals 800-776-3637 | Letter from King Pharmaceuticals |
Inversine (mecamylamine hydrochloride) Tablets, 2.5 mg 6/17/2009 | Targacept, Inc. 336-480-2100 | Dear Healthcare Professional Letter |
Inulin in Sodium Chloride Injection, USP 9/26/2003 | Questcor Pharmaceuticals, Inc. | Letter |
Kefzol (cefazolin) all presentations 2/28/2003 | Eli Lilly and Company | Letter |
Kefurox (cefuroxime) all presentations 2/28/2003 | Eli Lilly and Company | Letter |
Kemadrin (procyclidine hydrochloride) 6/6/2008 | King Pharmaceuticals 800-776-3637 | Letter from King Pharmaceuticals |
Lanoxin Elixir(digoxin) 6/3/2005 | GlaxoSmithKline | This product has been discontinued by GSK. Roxane is producing digoxin elixir. |
LEXXEL (enalapril maleate-felodipine ER) Tablets 12/19/2007 | AstraZeneca LP (AstraZeneca) - Contact Corporate Information Center at 800-236-9933. | LEXXEL Tablets will be discontinued on July 31, 2008. AstraZeneca has no further plans to manufacture or distribute LEXXEL (enalapril maleate-felodipine ER) Tablets after July 31, 2008. |
Lorabid (loracarbef, USP) capsules and suspension 10/27/2006 | King Pharmaceuticals 888-840-5370 | Letter from King Pharmaceuticals |
Luveris (lutropin alfa for injection) 5/31/2012 | EMD Serono Customer Service: 1-800-283-8088 | Business decision to discontinue. Please see the Dear Healthcare Professional Letter (PDF - 24KB). |
Mandol (cefamandole) all presentations 2/28/2003 | Eli Lilly and Company | Letter |
Mebaral (mephobarbital) 32mg tablets, 50mg tablets and 100mg tablets | Lundbeck Inc. Customer service number: | Lundbeck is no longer able to manufacture Mebaral CIV (brand of mephobarbital tablets, USP), and the company's remaining inventory will expire in March 2012. Due to product expiration, we will not be able to make any product shipments after February 29, 2012. Once this current stock of Mebaral is depleted, the product will no longer be available. Lundbeck is aware of the difficult situation that some patients may face with regard to the upcoming Mebaral discontinuation. The company thoroughly evaluated all avenues for keeping Mebaral available to patients, but ultimately concluded that no matter what steps we took, patients would be forced to transition to a new therapy. Due to the limited remaining Mebaral supply, we encourage patients to work with their physician to transition to alternative therapies rather than starting a new course of therapy with Mebaral. For more information or with questions, Lundbeck’s medical information team can be reached at 866-402-8520. |
Mebendazole Tablets 10/26/2011 | Teva Pharmaceuticals 1-800-545-8800 | Dear Valued Customer Letter (PDF - 43KB) |
Methergine (methylergonovine maleate) Injection and Tablets
4/12/2012 | Novartis Pharmaceuticals Corporation 1-888-NOW-NOVA | Novartis Pharmaceuticals Corporation has made a decision to discontinue Methergine (methylergonovine maleate) tablets and injection. |
Mitozytrex (Mitomycin for Injection) 9/12/2008 | SuperGen (925) 560-0100 | Other Mitomycin approved products continue to be available. This product was never commercialized. |
Mivacron (mivacurium chloride) injection 6/23/2006 | Abbott Laboratories | Alternative products that can be used in place of Mivacron continue to be available. Please call Abbott at 1-800-633-9110 for additional information. |
Moban (molindone hydrochloride) 1/13/2010 | Endo Pharmaceuticals Inc. 1-800-462-ENDO (1-800-462-3636) | Moban tablets have been discontinued and supplies are anticipated to be depleted by June 30, 2010. |
Mytelase (Ambenonium Chloride)
6/25/2012 | Sanofi-Aventis 1-800-981-2491 | Mytelase (ambenonium chloride) Tablets, indicated for the treatment of patients with myasthenia gravis, has been discontinued. The product discontinuation is not related to product safety or any FDA action. Sanofi communicated this decision to FDA on October 6, 2010. The last manufactured LOT of Mytelase® will expire on March 31, 2013 |
Naltrexone Oral Tablets
| Sandoz Customer Service: 1-609-627-8500 | Product is discontinued. Sandox is no longer distributing with no plans for re-introduction. |
Nandrolone Decanoate Injection 6/24/2009 | Watson Pharmaceuticals (800) 272-5525 | Watson Pharmaceuticals has discontinued this product because of the unavailability of the active pharmaceutical ingredient. |
Neutrexin (trimetrexate glucuronate) Injection 6/14/2007 | MedImmune, Inc. | Dear Healthcare Professional Letter |
Nimotop (nimodipine) capsules 10/31/2008 | Bayer HealthCare Pharmaceuticals 888-842-2937 | Generic nimodipine remains available.
|
Nolvadex (tamoxifen citrate) 4/10/2006 | AstraZeneca 800-236-9933 | Letter |
Novolin InnoLet disposable pens and Novolin PenFill 3 mL cartridges for Novolin R, N and 70/30 8/13/2009 | Novo Nordisk 1-800-727-6500 | Dear Healthcare Provider Letter Dear Patient Letter |
Novolin L, Lente, human insulin zinc suspension [rDNA origin] 7/15/2003
| Novo Nordisk Pharmaceuticals, Inc. Contact:
| Letter |
NPH Iletin II (ISOPHANE INSULIN SUSPENSION, USP, PURIFIED PORK) 7/6/2005 | Eli Lilly and Company |
|
Ondansetron Injection, 2 mg/mL 2 mL vials, package of 5 (NDC 60505-0744-01) 20 mL multiple dose vial (NDC 60505-0744-06) 4/10/2012 | Apotex Corporation Customer Service: 1-(877)-4-Apotex | Apotex has discontinued the manufacturing of Ondansetron Injection. |
Ondansetron Injection 32 mg/50 mL premixed bags 5/18/2012 | West-Ward Pharmaceuticals Customer Service: 1-888-229-0001 | West-Ward no longer distributes Ondansetron premixed bags. |
Opana ER strengths 7.5 mg and 15 mg 3/1/2011 | Endo Pharmaceuticals Inc. 1-800-462-ENDO (1-800-462-3636) | Endo Pharmaceuticals Inc. has have made a business decision to discontinue the 7.5 mg and 15 mg strengths. The 7.5 mg and 15 mg strengths will continue to be available through pharmacies until all inventory is depleted. All other strengths remain available. Dear Valued Customer Letter (PDF - 55KB) |
Original Prefilled Pen that Contains Humalog, Humalog Mix 75/25, and Humalog Mix 50/50 10/26/2010 | Eli Lilly and Company |
By the end of October, it is anticipated that the original Prefilled Pen containing Humalog Mix50/50 will no longer be available for ordering or shipping by wholesalers, distributors and pharmacy buyers. Supplies will be depleted by that time, and additional product will not be manufactured. At this time, the original Prefilled Pen containing Humalog or Humalog Mix75/25 continues to be available and orders will be shipped until supplies are exhausted.
|
ORLAAM (Levomethadyl hydrochloride acetate) Oral Solution, 10 mg/mL 9/2/2003 | Roxane Laboratories | Letter |
Pancrease (pancrelipase) capsules 5/17/2006 | McNeil Consumer and Specialty Pharmaceuticals 888-440-7903 | Other pancrelipase products continue to be available |
Pentothal (thiopental) Injection 1/25/2011 | Hospira Pharmaceuticals 1-877-946-7747 | Hospira has made the decision to discontinue this product. |
Perchloracap (potassium perchlorate) 200 mg capsules 6/2/2005 | Tyco Healthcare | Perchloracap capsules have been discontinued and supplies are anticipated to be depleted by the end of 2005. |
4/5/2012 | Pharmaceutical Associates, Inc 1-864-277-7282 | PAI has discontinued manufacturing of Phenobarbital Oral Solution (20mg/5mL) 5 mL unit dose package (NDC-00121-0531-05). |
Pontocaine HCL Injection (all products) 12/9/2010 | Hospira, Inc. 1-877-946-7747 | Hospira has made a business decision to discontinue these products. http://hospiraadvancewithus.com/ |
Potassium Citrate and Citric Acid Oral Solution
4/5/2012 | Pharmaceutical Associates, Inc 1-864-277-7282 | PAI has discontinued manufacturing of Potassium Citrate and Citric Acid Oral Solution: Potassium Citrate Monohydrate 1100 mg/5 ml; Citric Acid Monohydrate 334 mg/5 ml (NDC 00121-0676-16). |
Procanbid (Procanamide Hydrochloride Extended-Release Tablets) 11/9/2007 | King Pharmaceuticals 800-776-3637 | Dear Prescriber Letter |
5/2/2007 | Abbott 200 Abbott Park Road Abbott Park, IL 60064-6157 Customer Service: 800-633-9110 | Dear Health Care Provider Letter |
Pulmicort Turbuhaler 200mcg (budesonide inhalation powder) 5/16/2007 | AztraZeneca 1800 Concord Pike PO Box 8355 Wilmington DE 19803-8355 Corporate Information: 800-842-9920 | NDA 20-441, PULMICORT TURBUHALER 200 mcg (budesonide inhalation powder) will no longer be available at AstraZeneca. The introduction of PULMICORT FLEXHALER (budesonide inhalation powder, 90 & 180 mcg), NDA 21-949, will be accompanied by the phasing out of PULMICORT TURBUHALER so as to minimize confusion in the marketplace. AstraZeneca has no further plans to manufacture NDA 20-441, PULMICORT TURBUHALER 200 mcg (budesonide inhalation powder). |
Refludan (lepirudin (rDNA)) for Injection 5/17/2012 | Bayer Healthcare Corporation Customer Service: 1-888-229-0001 | Bayer Healthcare Corporation has made a decision to discontinue Refludan (lepirudin (rDNA)) for Injection. No further product will be distributed from Bayer after May 31, 2012. |
Regular Iletin II (INSULIN INJECTION, USP, PURIFIED PORK) 7/6/2005 | Eli Lilly and Company |
|
Revex (Nalmefene HCl Injection) 1mg/mL, 2 mL ampule and 0.1mg/mL, 1mL ampule 7/9/2008 | Baxter Healthcare Corporation 888-229-0001 | Baxter has discontinued Revex production. |
Roferon-A (Interferon alfa-2a, Recombinant) 11/29/2007 | Hoffmann -La Roche Inc. 800-526-6367 | Dear Healthcare Professional Letter |
SecreFlo (porcine secretin for injection, 16 mcg/vial) 10/1/2008 | ChiRhoClin, Inc., 1-877-272-4888 | Please see Dear Healthcare Professional Letter for additional information. |
Serevent Inhalation Aerosol 6/10/2003 | GlaxoSmithKline 800-340-3236 | GSK anticipates that SEREVENT Inhalation Aerosol will no longer be available starting in June 2003. |
Sporanox (itraconazole) Injection 10/11/2007 | Ortho Biotech | Please see Dear Health Care Professional letter for additional information. |
Stelazine (trifluoperazine) oral concentrate 10mg/ml Stelazine (trifluoperazine) tablets (1mg, 2mg, 5mg, 10mg) Stelazine (trifluoperazine) Injection 2mg/ml 12/18/2003 | GlaxoSmithKline 888-825-5249 | Stelazine was discontinued and withdrawn from the market. The final lots were distributed by GSK August 2003 and the final expiry date of all products in the marketplace is no later than January 31, 2004. |
Suprax (cefixime) updated 2/25/2004 | Lederle/Wyeth Pharmaceuticals | Discontinued July 2002. Stock will be distributed until exhausted or until March 2003, whichever comes first. For additional information, please call customer service (800) 666-7248 Lupin Pharmaceuticals recently received approval for cefixime 400 mg tablets and cefixime 100 mg/5 ml suspension. For further information, please contact Lupin Pharmaceuticals at 410-576-2000 (2/25/2004) |
Tenormin (atenolol) 0.5mg/ml Injection 2/28/2008 | AstraZeneca Pharmaceuticals LP (AstraZeneca) – Contact Corporate Information Center: 800-236-9933 | AstraZeneca has made a business decision to discontinue Tenormin (atenolol) 0.5 mg/ml injection. |
Teslac (testolactone tablets, USP) 50mg tablets 2/26/2008 | Bristol-Myers Squibb 609-897-2412 | Bristol-Myers Squibb Company has made a decision to discontinue Teslac (testolactone tablets, USP) 50mg tablets. |
Tequin (gatifloxacin) Tablets and Injection 5/12/2006 | Bristol-Meyers Squibb | See attached letter |
Tilade Inhaler (nedocromil sodium inhalation aerosol) 5/2/2008 | King Pharmaceuticals 800-776-3637 | Dear Healthcare Professional Letter (4/30/2008) |
Tricitrates Oral Solution 4/5/2012 | Pharmaceutical Associates, Inc Customer Service: 1-864-277-7282 | PAI has discontinued manufacturing of Tricitrates Oral Solution: Potassium Citrate Monohydrate 550 mg/5 mL; Sodium Citrate Dihydrate 500 mg/5 mL; Citric Acid Monohydrate 334 mg /5 mL (NDC 00121-0779-16). |
4/5/2012 | Pharmaceutical Associates, Inc 1-864-277-7282 | PAI has discontinued manufacturing of Tricitrates SF Oral Solution: Potassium Citrate Monohydrate 550 mg/5 mL; Sodium Citrate Dihydrate 500 mg/5 mL; Citric Acid Monohydrate 334 mg /5 mL (NDC 00121-0677-16). |
Valstar (valrubicin) Solution for Intravesical Instillation 1/30/2004 | Formerly distributed by Celltech Celltech Customer Service 888-963-3382 | No further availability planned at this time. |
Velosulin BR Human, Buffered Regular Human Insulin Injection [rDNA origin] 11/3/2003 | Novo Nordisk Pharmaceuticals, Inc. Contact: 800-727-6500 Customer Service | Dear Healthcare Professional Letter |
Vesanoid (tretinoin) Soft Gelatin Capsule 10 mg 12/17/2009 | Hoffmann-La Roche Inc | Please see the Dear Customer Letter titled: Vesanoid 10mg (tretinoin) Product Deletion at: Vesanoid Teva is increasing supply of their tretinoin 10mg capsules to meet market demand (NDC 00555-0808-02). |
Videx (didanosine) chewable/dispersable buffered tablets 9/19/2006 | BMS | Dear Healthcare Professional Letter |
1.5% Xylocaine -MPF with Dextrose 7.5% Injection (lidocaine HCl and dextrose anhydrous Injection ampules) 8/29/2005 | AstraZeneca 800-842-9920 | 1.5% Xylocaine® -MPF with Dextrose 7.5% Injection is no longer available at AstraZeneca. The remaining inventory of 1.5% Xylocaine® -MPF with Dextrose 7.5% Injection Ampules will be depleted by August 31, 2005. AstraZeneca has no further plans to manufacture 1.5% Xylocaine® -MPF with Dextrose 7.5% Injection Ampules |
Zenapax (daclizumab) sterile Concentrate for Injection 12/18/2009 | Hoffman-La Roche | Please see Dear Healthcare Professional Letter for additional information |
Zovirax (acyclovir sodium) for injection 1000mg/20ml vial 1/6/2004 | GlaxoSmithKline Customer Service 800-877-1158 | Letter from GSK |
Zyflo (zileuton) tablets 2/20/2008 | Critical Therapeutics, Inc. | Zyflo CR continues to be available. |